Tumor lysis syndrome |
Elevated lactate dehydrogenase (LDH), uric Acid, Potassium, ±phosphorus. AKI |
Aggressive fluid resuscitation with isotonic fluids, management of hyperkalemia if indicated, immediate emergency room evaluation and hospitalization |
Venous thromboembolism |
Unilateral lower extremity swelling, erythema, pain. Sudden onset dyspnea/hypoxia. |
If stable for outpatient management, low molecular weight heparin (LMWH), apixaban, rivaroxaban have the most evidence for anticoagulation in patients with malignancy |
Paraneoplastic processes |
Neurologic symptoms, dermatologic changes, fever, hematologic abnormalities, arthralgias, renal dysfunction, angioedema |
Commensurate with the severity of presentation. Evidence of MAHA, severe neurologic involvement, rash and fever, severe AKI should be referred to the ED |
Compressive or infiltrative tumor effects |
Hepatic or renal dysfunction Evidence of neurovascular compromise including claudication, bowel or bladder dysfunction, saddle anesthesia, motor or sensory dysfunction. |
Commensurate with the severity of presentation Severe hepatic or renal dysfunction, evidence of cauda equina syndrome, or rapidly progressive motor/sensory changes should be referred to the ED |